患有无质性贫血的老年患者:现实世界的治疗模式和结果
Bruno Fattizzo1,2, Carmelo Gurnari3,4, Sabrina Giammarco5
1Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
American journal of hematology
|January 29, 2025
概括
患有无形性贫血 (AA) 的老年患者经历了更糟糕的结果,并且对一线治疗的反应率更低. 高龄是AA死亡率的重要预测因素,需要优化临床管理策略.
科学领域:
- 血液学 血液学 血液学
- 老年医学 老年医学
- 在瘤学瘤学.
背景情况:
- 无形性贫血 (AA) 是一种罕见的骨髓衰竭疾病.
- 患有AA的老年患者的结局尚未明确.
- 对AA的治疗策略已经发展,包括使用血栓形成素受体激动剂 (TPO-RAs).
研究的目的:
- 为了比较治疗选择和老年人与患有无形性贫血的年轻患者的治疗结果.
- 确定与无塑性贫血死亡相关的因素,特别是在老年人中.
主要方法:
- 对1113名无形成性贫血患者的大型国际队列的回顾性分析.
- 60岁以上的患者和年轻患者之间的治疗反应和生存率的比较.
- 多变量分析以确定死亡率预测因素.
主要成果:
- 老年患者 (≥60岁) 呈现出更严重的血小板缺血症,并且对一线治疗的反应率明显较低 (47%vs65%).
- 高龄是与死亡率相关的主要因素 (HR 1.64),其次是疾病严重程度和男性性别.
- 老年患者的发展率更高,发展为肌肉发育综合征 (MDS) (12%对比7%).
结论:
- 老年无形性贫血患者面临较差的结果,即使使用TPO-RAs等当前疗法.
- 年龄,疾病严重程度和男性性别是无塑性贫血死亡率的关键预测因素.
- 进一步优化临床管理对于改善无塑性贫血老年患者的治疗结果至关重要.
更多相关视频
03:22Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
Published on: January 27, 2018
15.0K
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
16.3K
相关概念视频
Bone Marrow Sampling and Transplants
277
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
277
Tissue Transplantation
333
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
333
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
